nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—CYP1A1—Clobetasol propionate—psoriasis	0.109	0.139	CbGbCtD
Propranolol—CYP1A1—Methoxsalen—psoriasis	0.0571	0.0731	CbGbCtD
Propranolol—CYP3A5—Beclomethasone—psoriasis	0.0494	0.0633	CbGbCtD
Propranolol—CYP1A2—Clobetasol propionate—psoriasis	0.0485	0.0622	CbGbCtD
Propranolol—CYP1A1—Cholecalciferol—psoriasis	0.0378	0.0484	CbGbCtD
Propranolol—CYP1A2—Methoxsalen—psoriasis	0.0255	0.0327	CbGbCtD
Propranolol—CYP2D6—Hydroxyurea—psoriasis	0.023	0.0294	CbGbCtD
Propranolol—CYP3A7—Hydrocortisone—psoriasis	0.021	0.027	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.021	0.027	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0199	0.0255	CbGbCtD
Propranolol—CYP3A7—Cyclosporine—psoriasis	0.0199	0.0255	CbGbCtD
Propranolol—CYP3A5—Mycophenolate mofetil—psoriasis	0.0197	0.0252	CbGbCtD
Propranolol—CYP2C19—Cholecalciferol—psoriasis	0.0183	0.0234	CbGbCtD
Propranolol—CYP3A4—Calcitriol—psoriasis	0.0172	0.022	CbGbCtD
Propranolol—CYP1A1—Dexamethasone—psoriasis	0.0164	0.021	CbGbCtD
Propranolol—CYP3A5—Hydrocortisone—psoriasis	0.0158	0.0202	CbGbCtD
Propranolol—CYP3A5—Cyclosporine—psoriasis	0.0149	0.0191	CbGbCtD
Propranolol—CYP2D6—Cholecalciferol—psoriasis	0.0139	0.0178	CbGbCtD
Propranolol—CYP3A4—Methoxsalen—psoriasis	0.0134	0.0171	CbGbCtD
Propranolol—CYP3A7—Dexamethasone—psoriasis	0.0131	0.0168	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0131	0.0168	CbGbCtD
Propranolol—ABCB1—Mycophenolate mofetil—psoriasis	0.0128	0.0164	CbGbCtD
Propranolol—CYP2C19—Prednisone—psoriasis	0.0127	0.0163	CbGbCtD
Propranolol—CYP2C19—Cyclosporine—psoriasis	0.012	0.0154	CbGbCtD
Propranolol—ABCB1—Betamethasone—psoriasis	0.011	0.0141	CbGbCtD
Propranolol—ABCB1—Prednisolone—psoriasis	0.0108	0.0139	CbGbCtD
Propranolol—ABCB1—Hydrocortisone—psoriasis	0.0103	0.0132	CbGbCtD
Propranolol—ABCB1—Prednisone—psoriasis	0.0102	0.0131	CbGbCtD
Propranolol—CYP3A5—Dexamethasone—psoriasis	0.00982	0.0126	CbGbCtD
Propranolol—ABCB1—Cyclosporine—psoriasis	0.0097	0.0124	CbGbCtD
Propranolol—CYP2D6—Cyclosporine—psoriasis	0.00914	0.0117	CbGbCtD
Propranolol—CYP3A4—Cholecalciferol—psoriasis	0.00885	0.0113	CbGbCtD
Propranolol—CYP2C19—Dexamethasone—psoriasis	0.00792	0.0101	CbGbCtD
Propranolol—CYP3A4—Mycophenolate mofetil—psoriasis	0.00767	0.00983	CbGbCtD
Propranolol—CYP3A4—Triamcinolone—psoriasis	0.00767	0.00983	CbGbCtD
Propranolol—CYP3A4—Betamethasone—psoriasis	0.00658	0.00843	CbGbCtD
Propranolol—CYP3A4—Prednisolone—psoriasis	0.00649	0.00832	CbGbCtD
Propranolol—ABCB1—Dexamethasone—psoriasis	0.00639	0.00819	CbGbCtD
Propranolol—CYP3A4—Hydrocortisone—psoriasis	0.00616	0.00789	CbGbCtD
Propranolol—CYP3A4—Prednisone—psoriasis	0.00613	0.00786	CbGbCtD
Propranolol—CYP2D6—Dexamethasone—psoriasis	0.00602	0.00771	CbGbCtD
Propranolol—CYP3A4—Cyclosporine—psoriasis	0.00581	0.00745	CbGbCtD
Propranolol—ABCB1—Methotrexate—psoriasis	0.00513	0.00658	CbGbCtD
Propranolol—CYP3A4—Dexamethasone—psoriasis	0.00383	0.0049	CbGbCtD
Propranolol—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000189	0.00101	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000189	0.00101	CcSEcCtD
Propranolol—Diarrhoea—Hydroxyurea—psoriasis	0.000189	0.00101	CcSEcCtD
Propranolol—Vertigo—Prednisolone—psoriasis	0.000187	0.000999	CcSEcCtD
Propranolol—Anaphylactic shock—Cyclosporine—psoriasis	0.000187	0.000998	CcSEcCtD
Propranolol—Infection—Cyclosporine—psoriasis	0.000186	0.000991	CcSEcCtD
Propranolol—Nervous system disorder—Cyclosporine—psoriasis	0.000183	0.000978	CcSEcCtD
Propranolol—Vertigo—Hydrocortisone—psoriasis	0.000183	0.000976	CcSEcCtD
Propranolol—Abdominal pain—Mycophenolic acid—psoriasis	0.000183	0.000975	CcSEcCtD
Propranolol—Body temperature increased—Mycophenolic acid—psoriasis	0.000183	0.000975	CcSEcCtD
Propranolol—Dizziness—Hydroxyurea—psoriasis	0.000182	0.000974	CcSEcCtD
Propranolol—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000182	0.000973	CcSEcCtD
Propranolol—Skin disorder—Cyclosporine—psoriasis	0.000181	0.000969	CcSEcCtD
Propranolol—Infection—Mycophenolate mofetil—psoriasis	0.000181	0.000967	CcSEcCtD
Propranolol—Convulsion—Prednisolone—psoriasis	0.00018	0.000964	CcSEcCtD
Propranolol—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000179	0.000954	CcSEcCtD
Propranolol—Skin disorder—Mycophenolate mofetil—psoriasis	0.000177	0.000945	CcSEcCtD
Propranolol—Bradycardia—Prednisone—psoriasis	0.000177	0.000945	CcSEcCtD
Propranolol—Alopecia—Dexamethasone—psoriasis	0.000176	0.000942	CcSEcCtD
Propranolol—Alopecia—Betamethasone—psoriasis	0.000176	0.000942	CcSEcCtD
Propranolol—Convulsion—Hydrocortisone—psoriasis	0.000176	0.000941	CcSEcCtD
Propranolol—Vomiting—Hydroxyurea—psoriasis	0.000175	0.000936	CcSEcCtD
Propranolol—Rash—Hydroxyurea—psoriasis	0.000174	0.000928	CcSEcCtD
Propranolol—Erythema—Dexamethasone—psoriasis	0.000174	0.000928	CcSEcCtD
Propranolol—Erythema—Betamethasone—psoriasis	0.000174	0.000928	CcSEcCtD
Propranolol—Dermatitis—Hydroxyurea—psoriasis	0.000174	0.000927	CcSEcCtD
Propranolol—Hallucination—Prednisone—psoriasis	0.000173	0.000924	CcSEcCtD
Propranolol—Vertigo—Triamcinolone—psoriasis	0.000172	0.000919	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000172	0.000918	CcSEcCtD
Propranolol—Anaphylactic shock—Prednisolone—psoriasis	0.00017	0.000908	CcSEcCtD
Propranolol—Neutropenia—Methotrexate—psoriasis	0.00017	0.000906	CcSEcCtD
Propranolol—Insomnia—Cyclosporine—psoriasis	0.000169	0.000902	CcSEcCtD
Propranolol—Paraesthesia—Cyclosporine—psoriasis	0.000168	0.000896	CcSEcCtD
Propranolol—Erectile dysfunction—Methotrexate—psoriasis	0.000167	0.000893	CcSEcCtD
Propranolol—Cough—Triamcinolone—psoriasis	0.000167	0.000893	CcSEcCtD
Propranolol—Dyspnoea—Cyclosporine—psoriasis	0.000167	0.000889	CcSEcCtD
Propranolol—Somnolence—Cyclosporine—psoriasis	0.000166	0.000887	CcSEcCtD
Propranolol—Anaphylactic shock—Hydrocortisone—psoriasis	0.000166	0.000887	CcSEcCtD
Propranolol—Convulsion—Triamcinolone—psoriasis	0.000166	0.000886	CcSEcCtD
Propranolol—Asthenia—Mycophenolic acid—psoriasis	0.000166	0.000885	CcSEcCtD
Propranolol—Infection—Hydrocortisone—psoriasis	0.000165	0.000881	CcSEcCtD
Propranolol—Insomnia—Mycophenolate mofetil—psoriasis	0.000165	0.00088	CcSEcCtD
Propranolol—Dyspepsia—Cyclosporine—psoriasis	0.000164	0.000878	CcSEcCtD
Propranolol—Nausea—Hydroxyurea—psoriasis	0.000164	0.000875	CcSEcCtD
Propranolol—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000164	0.000874	CcSEcCtD
Propranolol—Nervous system disorder—Hydrocortisone—psoriasis	0.000163	0.000869	CcSEcCtD
Propranolol—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000162	0.000868	CcSEcCtD
Propranolol—Decreased appetite—Cyclosporine—psoriasis	0.000162	0.000867	CcSEcCtD
Propranolol—Somnolence—Mycophenolate mofetil—psoriasis	0.000162	0.000865	CcSEcCtD
Propranolol—Infestation NOS—Methotrexate—psoriasis	0.000162	0.000864	CcSEcCtD
Propranolol—Infestation—Methotrexate—psoriasis	0.000162	0.000864	CcSEcCtD
Propranolol—Depression—Methotrexate—psoriasis	0.000161	0.000862	CcSEcCtD
Propranolol—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000161	0.000861	CcSEcCtD
Propranolol—Skin disorder—Hydrocortisone—psoriasis	0.000161	0.000861	CcSEcCtD
Propranolol—Fatigue—Cyclosporine—psoriasis	0.000161	0.00086	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.00016	0.000857	CcSEcCtD
Propranolol—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00016	0.000857	CcSEcCtD
Propranolol—Pain—Cyclosporine—psoriasis	0.00016	0.000853	CcSEcCtD
Propranolol—Constipation—Cyclosporine—psoriasis	0.00016	0.000853	CcSEcCtD
Propranolol—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000158	0.000846	CcSEcCtD
Propranolol—Diarrhoea—Mycophenolic acid—psoriasis	0.000158	0.000844	CcSEcCtD
Propranolol—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000157	0.00084	CcSEcCtD
Propranolol—Anaphylactic shock—Triamcinolone—psoriasis	0.000156	0.000835	CcSEcCtD
Propranolol—Vertigo—Betamethasone—psoriasis	0.000156	0.000834	CcSEcCtD
Propranolol—Vertigo—Dexamethasone—psoriasis	0.000156	0.000834	CcSEcCtD
Propranolol—Pain—Mycophenolate mofetil—psoriasis	0.000156	0.000832	CcSEcCtD
Propranolol—Constipation—Mycophenolate mofetil—psoriasis	0.000156	0.000832	CcSEcCtD
Propranolol—Infection—Triamcinolone—psoriasis	0.000155	0.000829	CcSEcCtD
Propranolol—Insomnia—Prednisolone—psoriasis	0.000154	0.000821	CcSEcCtD
Propranolol—Alopecia—Prednisone—psoriasis	0.000154	0.00082	CcSEcCtD
Propranolol—Gastrointestinal pain—Cyclosporine—psoriasis	0.000153	0.000816	CcSEcCtD
Propranolol—Dizziness—Mycophenolic acid—psoriasis	0.000153	0.000815	CcSEcCtD
Propranolol—Paraesthesia—Prednisolone—psoriasis	0.000153	0.000815	CcSEcCtD
Propranolol—Mental disorder—Prednisone—psoriasis	0.000152	0.000813	CcSEcCtD
Propranolol—Erythema—Prednisone—psoriasis	0.000151	0.000808	CcSEcCtD
Propranolol—Agranulocytosis—Methotrexate—psoriasis	0.000151	0.000807	CcSEcCtD
Propranolol—Convulsion—Dexamethasone—psoriasis	0.000151	0.000804	CcSEcCtD
Propranolol—Convulsion—Betamethasone—psoriasis	0.000151	0.000804	CcSEcCtD
Propranolol—Insomnia—Hydrocortisone—psoriasis	0.00015	0.000802	CcSEcCtD
Propranolol—Paraesthesia—Hydrocortisone—psoriasis	0.000149	0.000796	CcSEcCtD
Propranolol—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000149	0.000796	CcSEcCtD
Propranolol—Urticaria—Cyclosporine—psoriasis	0.000148	0.000792	CcSEcCtD
Propranolol—Abdominal pain—Cyclosporine—psoriasis	0.000148	0.000789	CcSEcCtD
Propranolol—Body temperature increased—Cyclosporine—psoriasis	0.000148	0.000789	CcSEcCtD
Propranolol—Vomiting—Mycophenolic acid—psoriasis	0.000147	0.000784	CcSEcCtD
Propranolol—Dyspepsia—Hydrocortisone—psoriasis	0.000146	0.00078	CcSEcCtD
Propranolol—Rash—Mycophenolic acid—psoriasis	0.000146	0.000777	CcSEcCtD
Propranolol—Dermatitis—Mycophenolic acid—psoriasis	0.000145	0.000777	CcSEcCtD
Propranolol—Pain—Prednisolone—psoriasis	0.000145	0.000776	CcSEcCtD
Propranolol—Urticaria—Mycophenolate mofetil—psoriasis	0.000145	0.000773	CcSEcCtD
Propranolol—Decreased appetite—Hydrocortisone—psoriasis	0.000144	0.000771	CcSEcCtD
Propranolol—Pharyngitis—Methotrexate—psoriasis	0.000144	0.00077	CcSEcCtD
Propranolol—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000144	0.000769	CcSEcCtD
Propranolol—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000144	0.000769	CcSEcCtD
Propranolol—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000143	0.000765	CcSEcCtD
Propranolol—Fatigue—Hydrocortisone—psoriasis	0.000143	0.000764	CcSEcCtD
Propranolol—Pain—Hydrocortisone—psoriasis	0.000142	0.000758	CcSEcCtD
Propranolol—Anaphylactic shock—Dexamethasone—psoriasis	0.000142	0.000757	CcSEcCtD
Propranolol—Anaphylactic shock—Betamethasone—psoriasis	0.000142	0.000757	CcSEcCtD
Propranolol—Insomnia—Triamcinolone—psoriasis	0.000141	0.000755	CcSEcCtD
Propranolol—Infection—Betamethasone—psoriasis	0.000141	0.000752	CcSEcCtD
Propranolol—Infection—Dexamethasone—psoriasis	0.000141	0.000752	CcSEcCtD
Propranolol—Paraesthesia—Triamcinolone—psoriasis	0.00014	0.00075	CcSEcCtD
Propranolol—Visual impairment—Methotrexate—psoriasis	0.00014	0.000748	CcSEcCtD
Propranolol—Dyspnoea—Triamcinolone—psoriasis	0.000139	0.000744	CcSEcCtD
Propranolol—Nervous system disorder—Betamethasone—psoriasis	0.000139	0.000743	CcSEcCtD
Propranolol—Nervous system disorder—Dexamethasone—psoriasis	0.000139	0.000743	CcSEcCtD
Propranolol—Agitation—Prednisone—psoriasis	0.000139	0.000743	CcSEcCtD
Propranolol—Hypersensitivity—Cyclosporine—psoriasis	0.000138	0.000735	CcSEcCtD
Propranolol—Dyspepsia—Triamcinolone—psoriasis	0.000138	0.000735	CcSEcCtD
Propranolol—Erythema multiforme—Methotrexate—psoriasis	0.000137	0.000734	CcSEcCtD
Propranolol—Nausea—Mycophenolic acid—psoriasis	0.000137	0.000732	CcSEcCtD
Propranolol—Vertigo—Prednisone—psoriasis	0.000136	0.000726	CcSEcCtD
Propranolol—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000136	0.000725	CcSEcCtD
Propranolol—Urticaria—Prednisolone—psoriasis	0.000135	0.000721	CcSEcCtD
Propranolol—Cardiac disorder—Methotrexate—psoriasis	0.000135	0.00072	CcSEcCtD
Propranolol—Fatigue—Triamcinolone—psoriasis	0.000135	0.00072	CcSEcCtD
Propranolol—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000134	0.000717	CcSEcCtD
Propranolol—Asthenia—Cyclosporine—psoriasis	0.000134	0.000716	CcSEcCtD
Propranolol—Pain—Triamcinolone—psoriasis	0.000134	0.000714	CcSEcCtD
Propranolol—Urticaria—Hydrocortisone—psoriasis	0.000132	0.000704	CcSEcCtD
Propranolol—Body temperature increased—Hydrocortisone—psoriasis	0.000131	0.000701	CcSEcCtD
Propranolol—Abdominal pain—Hydrocortisone—psoriasis	0.000131	0.000701	CcSEcCtD
Propranolol—Convulsion—Prednisone—psoriasis	0.000131	0.0007	CcSEcCtD
Propranolol—Asthenia—Mycophenolate mofetil—psoriasis	0.000131	0.000698	CcSEcCtD
Propranolol—Alopecia—Methotrexate—psoriasis	0.000128	0.000686	CcSEcCtD
Propranolol—Insomnia—Dexamethasone—psoriasis	0.000128	0.000685	CcSEcCtD
Propranolol—Insomnia—Betamethasone—psoriasis	0.000128	0.000685	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000128	0.000683	CcSEcCtD
Propranolol—Diarrhoea—Cyclosporine—psoriasis	0.000128	0.000683	CcSEcCtD
Propranolol—Paraesthesia—Dexamethasone—psoriasis	0.000127	0.00068	CcSEcCtD
Propranolol—Paraesthesia—Betamethasone—psoriasis	0.000127	0.00068	CcSEcCtD
Propranolol—Mental disorder—Methotrexate—psoriasis	0.000127	0.00068	CcSEcCtD
Propranolol—Erythema—Methotrexate—psoriasis	0.000126	0.000675	CcSEcCtD
Propranolol—Hypersensitivity—Prednisolone—psoriasis	0.000125	0.000669	CcSEcCtD
Propranolol—Dyspepsia—Betamethasone—psoriasis	0.000125	0.000667	CcSEcCtD
Propranolol—Dyspepsia—Dexamethasone—psoriasis	0.000125	0.000667	CcSEcCtD
Propranolol—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000125	0.000666	CcSEcCtD
Propranolol—Urticaria—Triamcinolone—psoriasis	0.000124	0.000663	CcSEcCtD
Propranolol—Body temperature increased—Triamcinolone—psoriasis	0.000124	0.00066	CcSEcCtD
Propranolol—Dizziness—Cyclosporine—psoriasis	0.000124	0.00066	CcSEcCtD
Propranolol—Anaphylactic shock—Prednisone—psoriasis	0.000124	0.00066	CcSEcCtD
Propranolol—Decreased appetite—Dexamethasone—psoriasis	0.000123	0.000658	CcSEcCtD
Propranolol—Decreased appetite—Betamethasone—psoriasis	0.000123	0.000658	CcSEcCtD
Propranolol—Infection—Prednisone—psoriasis	0.000123	0.000655	CcSEcCtD
Propranolol—Gastrointestinal disorder—Betamethasone—psoriasis	0.000122	0.000654	CcSEcCtD
Propranolol—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000122	0.000654	CcSEcCtD
Propranolol—Hypersensitivity—Hydrocortisone—psoriasis	0.000122	0.000653	CcSEcCtD
Propranolol—Fatigue—Betamethasone—psoriasis	0.000122	0.000653	CcSEcCtD
Propranolol—Fatigue—Dexamethasone—psoriasis	0.000122	0.000653	CcSEcCtD
Propranolol—Pain—Dexamethasone—psoriasis	0.000121	0.000648	CcSEcCtD
Propranolol—Pain—Betamethasone—psoriasis	0.000121	0.000648	CcSEcCtD
Propranolol—Nervous system disorder—Prednisone—psoriasis	0.000121	0.000647	CcSEcCtD
Propranolol—Dizziness—Mycophenolate mofetil—psoriasis	0.000121	0.000644	CcSEcCtD
Propranolol—Skin disorder—Prednisone—psoriasis	0.00012	0.000641	CcSEcCtD
Propranolol—Asthenia—Hydrocortisone—psoriasis	0.000119	0.000636	CcSEcCtD
Propranolol—Vomiting—Cyclosporine—psoriasis	0.000119	0.000634	CcSEcCtD
Propranolol—Rash—Cyclosporine—psoriasis	0.000118	0.000629	CcSEcCtD
Propranolol—Dermatitis—Cyclosporine—psoriasis	0.000118	0.000628	CcSEcCtD
Propranolol—Gastrointestinal pain—Betamethasone—psoriasis	0.000116	0.000619	CcSEcCtD
Propranolol—Gastrointestinal pain—Dexamethasone—psoriasis	0.000116	0.000619	CcSEcCtD
Propranolol—Vomiting—Mycophenolate mofetil—psoriasis	0.000116	0.000619	CcSEcCtD
Propranolol—Hypersensitivity—Triamcinolone—psoriasis	0.000115	0.000615	CcSEcCtD
Propranolol—Rash—Mycophenolate mofetil—psoriasis	0.000115	0.000614	CcSEcCtD
Propranolol—Dermatitis—Mycophenolate mofetil—psoriasis	0.000115	0.000613	CcSEcCtD
Propranolol—Vertigo—Methotrexate—psoriasis	0.000114	0.000607	CcSEcCtD
Propranolol—Diarrhoea—Hydrocortisone—psoriasis	0.000114	0.000607	CcSEcCtD
Propranolol—Urticaria—Dexamethasone—psoriasis	0.000113	0.000602	CcSEcCtD
Propranolol—Urticaria—Betamethasone—psoriasis	0.000113	0.000602	CcSEcCtD
Propranolol—Dizziness—Prednisolone—psoriasis	0.000112	0.0006	CcSEcCtD
Propranolol—Asthenia—Triamcinolone—psoriasis	0.000112	0.000599	CcSEcCtD
Propranolol—Body temperature increased—Dexamethasone—psoriasis	0.000112	0.000599	CcSEcCtD
Propranolol—Abdominal pain—Betamethasone—psoriasis	0.000112	0.000599	CcSEcCtD
Propranolol—Body temperature increased—Betamethasone—psoriasis	0.000112	0.000599	CcSEcCtD
Propranolol—Abdominal pain—Dexamethasone—psoriasis	0.000112	0.000599	CcSEcCtD
Propranolol—Insomnia—Prednisone—psoriasis	0.000112	0.000597	CcSEcCtD
Propranolol—Nausea—Cyclosporine—psoriasis	0.000111	0.000593	CcSEcCtD
Propranolol—Paraesthesia—Prednisone—psoriasis	0.000111	0.000592	CcSEcCtD
Propranolol—Cough—Methotrexate—psoriasis	0.00011	0.000589	CcSEcCtD
Propranolol—Dizziness—Hydrocortisone—psoriasis	0.00011	0.000586	CcSEcCtD
Propranolol—Convulsion—Methotrexate—psoriasis	0.00011	0.000585	CcSEcCtD
Propranolol—Dyspepsia—Prednisone—psoriasis	0.000109	0.000581	CcSEcCtD
Propranolol—Nausea—Mycophenolate mofetil—psoriasis	0.000108	0.000578	CcSEcCtD
Propranolol—Decreased appetite—Prednisone—psoriasis	0.000107	0.000573	CcSEcCtD
Propranolol—Rash—Prednisolone—psoriasis	0.000107	0.000572	CcSEcCtD
Propranolol—Dermatitis—Prednisolone—psoriasis	0.000107	0.000572	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000107	0.000571	CcSEcCtD
Propranolol—Fatigue—Prednisone—psoriasis	0.000107	0.000569	CcSEcCtD
Propranolol—Constipation—Prednisone—psoriasis	0.000106	0.000564	CcSEcCtD
Propranolol—Vomiting—Hydrocortisone—psoriasis	0.000106	0.000564	CcSEcCtD
Propranolol—Rash—Hydrocortisone—psoriasis	0.000105	0.000559	CcSEcCtD
Propranolol—Dermatitis—Hydrocortisone—psoriasis	0.000105	0.000558	CcSEcCtD
Propranolol—Dizziness—Triamcinolone—psoriasis	0.000103	0.000552	CcSEcCtD
Propranolol—Anaphylactic shock—Methotrexate—psoriasis	0.000103	0.000551	CcSEcCtD
Propranolol—Infection—Methotrexate—psoriasis	0.000103	0.000548	CcSEcCtD
Propranolol—Asthenia—Dexamethasone—psoriasis	0.000102	0.000543	CcSEcCtD
Propranolol—Asthenia—Betamethasone—psoriasis	0.000102	0.000543	CcSEcCtD
Propranolol—Nervous system disorder—Methotrexate—psoriasis	0.000101	0.000541	CcSEcCtD
Propranolol—Gastrointestinal pain—Prednisone—psoriasis	0.000101	0.000539	CcSEcCtD
Propranolol—Nausea—Prednisolone—psoriasis	0.000101	0.000539	CcSEcCtD
Propranolol—Skin disorder—Methotrexate—psoriasis	0.0001	0.000535	CcSEcCtD
Propranolol—Vomiting—Triamcinolone—psoriasis	9.94e-05	0.000531	CcSEcCtD
Propranolol—Nausea—Hydrocortisone—psoriasis	9.86e-05	0.000527	CcSEcCtD
Propranolol—Rash—Triamcinolone—psoriasis	9.86e-05	0.000526	CcSEcCtD
Propranolol—Dermatitis—Triamcinolone—psoriasis	9.85e-05	0.000526	CcSEcCtD
Propranolol—Urticaria—Prednisone—psoriasis	9.81e-05	0.000524	CcSEcCtD
Propranolol—Body temperature increased—Prednisone—psoriasis	9.77e-05	0.000521	CcSEcCtD
Propranolol—Abdominal pain—Prednisone—psoriasis	9.77e-05	0.000521	CcSEcCtD
Propranolol—Diarrhoea—Dexamethasone—psoriasis	9.71e-05	0.000518	CcSEcCtD
Propranolol—Diarrhoea—Betamethasone—psoriasis	9.71e-05	0.000518	CcSEcCtD
Propranolol—Dizziness—Dexamethasone—psoriasis	9.38e-05	0.000501	CcSEcCtD
Propranolol—Dizziness—Betamethasone—psoriasis	9.38e-05	0.000501	CcSEcCtD
Propranolol—Insomnia—Methotrexate—psoriasis	9.34e-05	0.000499	CcSEcCtD
Propranolol—Nausea—Triamcinolone—psoriasis	9.29e-05	0.000496	CcSEcCtD
Propranolol—Paraesthesia—Methotrexate—psoriasis	9.27e-05	0.000495	CcSEcCtD
Propranolol—Dyspnoea—Methotrexate—psoriasis	9.2e-05	0.000491	CcSEcCtD
Propranolol—Somnolence—Methotrexate—psoriasis	9.18e-05	0.00049	CcSEcCtD
Propranolol—Hypersensitivity—Prednisone—psoriasis	9.1e-05	0.000486	CcSEcCtD
Propranolol—Dyspepsia—Methotrexate—psoriasis	9.09e-05	0.000485	CcSEcCtD
Propranolol—Vomiting—Dexamethasone—psoriasis	9.02e-05	0.000482	CcSEcCtD
Propranolol—Vomiting—Betamethasone—psoriasis	9.02e-05	0.000482	CcSEcCtD
Propranolol—Decreased appetite—Methotrexate—psoriasis	8.97e-05	0.000479	CcSEcCtD
Propranolol—Rash—Dexamethasone—psoriasis	8.94e-05	0.000478	CcSEcCtD
Propranolol—Rash—Betamethasone—psoriasis	8.94e-05	0.000478	CcSEcCtD
Propranolol—Dermatitis—Betamethasone—psoriasis	8.94e-05	0.000477	CcSEcCtD
Propranolol—Dermatitis—Dexamethasone—psoriasis	8.94e-05	0.000477	CcSEcCtD
Propranolol—Gastrointestinal disorder—Methotrexate—psoriasis	8.91e-05	0.000476	CcSEcCtD
Propranolol—Fatigue—Methotrexate—psoriasis	8.9e-05	0.000475	CcSEcCtD
Propranolol—Asthenia—Prednisone—psoriasis	8.86e-05	0.000473	CcSEcCtD
Propranolol—Pain—Methotrexate—psoriasis	8.83e-05	0.000471	CcSEcCtD
Propranolol—Diarrhoea—Prednisone—psoriasis	8.45e-05	0.000451	CcSEcCtD
Propranolol—Gastrointestinal pain—Methotrexate—psoriasis	8.44e-05	0.000451	CcSEcCtD
Propranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	8.43e-05	0.00262	CbGpPWpGaD
Propranolol—Nausea—Betamethasone—psoriasis	8.43e-05	0.00045	CcSEcCtD
Propranolol—Nausea—Dexamethasone—psoriasis	8.43e-05	0.00045	CcSEcCtD
Propranolol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.28e-05	0.00257	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	8.25e-05	0.00256	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—CCL20—psoriasis	8.24e-05	0.00256	CbGpPWpGaD
Propranolol—Urticaria—Methotrexate—psoriasis	8.2e-05	0.000438	CcSEcCtD
Propranolol—Dizziness—Prednisone—psoriasis	8.17e-05	0.000436	CcSEcCtD
Propranolol—Abdominal pain—Methotrexate—psoriasis	8.16e-05	0.000436	CcSEcCtD
Propranolol—Body temperature increased—Methotrexate—psoriasis	8.16e-05	0.000436	CcSEcCtD
Propranolol—HTR1B—Signaling by GPCR—HCAR2—psoriasis	8.14e-05	0.00253	CbGpPWpGaD
Propranolol—Vomiting—Prednisone—psoriasis	7.85e-05	0.000419	CcSEcCtD
Propranolol—Rash—Prednisone—psoriasis	7.79e-05	0.000416	CcSEcCtD
Propranolol—Dermatitis—Prednisone—psoriasis	7.78e-05	0.000416	CcSEcCtD
Propranolol—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.76e-05	0.00241	CbGpPWpGaD
Propranolol—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.65e-05	0.00237	CbGpPWpGaD
Propranolol—Hypersensitivity—Methotrexate—psoriasis	7.61e-05	0.000406	CcSEcCtD
Propranolol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.56e-05	0.00234	CbGpPWpGaD
Propranolol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.48e-05	0.00232	CbGpPWpGaD
Propranolol—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.44e-05	0.00231	CbGpPWpGaD
Propranolol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	7.43e-05	0.0023	CbGpPWpGaD
Propranolol—Asthenia—Methotrexate—psoriasis	7.41e-05	0.000396	CcSEcCtD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.36e-05	0.00228	CbGpPWpGaD
Propranolol—Nausea—Prednisone—psoriasis	7.34e-05	0.000392	CcSEcCtD
Propranolol—ADRB1—GPCR downstream signaling—HCAR2—psoriasis	7.14e-05	0.00222	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—IL10—psoriasis	7.11e-05	0.00221	CbGpPWpGaD
Propranolol—Diarrhoea—Methotrexate—psoriasis	7.06e-05	0.000377	CcSEcCtD
Propranolol—ADRB2—GPCR downstream signaling—HCAR2—psoriasis	6.99e-05	0.00217	CbGpPWpGaD
Propranolol—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	6.85e-05	0.00212	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—HCAR2—psoriasis	6.83e-05	0.00212	CbGpPWpGaD
Propranolol—Dizziness—Methotrexate—psoriasis	6.83e-05	0.000365	CcSEcCtD
Propranolol—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.7e-05	0.00208	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—IL10—psoriasis	6.66e-05	0.00207	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—CCL20—psoriasis	6.57e-05	0.00204	CbGpPWpGaD
Propranolol—Vomiting—Methotrexate—psoriasis	6.56e-05	0.000351	CcSEcCtD
Propranolol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.53e-05	0.00203	CbGpPWpGaD
Propranolol—Rash—Methotrexate—psoriasis	6.51e-05	0.000348	CcSEcCtD
Propranolol—Dermatitis—Methotrexate—psoriasis	6.5e-05	0.000347	CcSEcCtD
Propranolol—ADRB1—Signaling by GPCR—HCAR2—psoriasis	6.49e-05	0.00201	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—IL4—psoriasis	6.48e-05	0.00201	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HCAR2—psoriasis	6.46e-05	0.002	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—CCL20—psoriasis	6.42e-05	0.00199	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HCAR2—psoriasis	6.35e-05	0.00197	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.33e-05	0.00197	CbGpPWpGaD
Propranolol—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.33e-05	0.00196	CbGpPWpGaD
Propranolol—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.29e-05	0.00195	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—CCL20—psoriasis	6.28e-05	0.00195	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—CCL20—psoriasis	6.25e-05	0.00194	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HCAR2—psoriasis	6.2e-05	0.00192	CbGpPWpGaD
Propranolol—Nausea—Methotrexate—psoriasis	6.13e-05	0.000327	CcSEcCtD
Propranolol—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.9e-05	0.00183	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.87e-05	0.00182	CbGpPWpGaD
Propranolol—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	5.8e-05	0.0018	CbGpPWpGaD
Propranolol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.77e-05	0.00179	CbGpPWpGaD
Propranolol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.71e-05	0.00177	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—CCL20—psoriasis	5.68e-05	0.00176	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TAGAP—psoriasis	5.6e-05	0.00174	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.36e-05	0.00166	CbGpPWpGaD
Propranolol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.89e-05	0.00152	CbGpPWpGaD
Propranolol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.89e-05	0.00152	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.82e-05	0.00149	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HCAR2—psoriasis	4.81e-05	0.00149	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—CCL20—psoriasis	4.66e-05	0.00145	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—NDUFA5—psoriasis	4.65e-05	0.00144	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—NDUFA5—psoriasis	4.64e-05	0.00144	CbGpPWpGaD
Propranolol—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	4.58e-05	0.00142	CbGpPWpGaD
Propranolol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	4.49e-05	0.00139	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	4.31e-05	0.00134	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—CCL20—psoriasis	4.23e-05	0.00131	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TAGAP—psoriasis	4.17e-05	0.00129	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.17e-05	0.00129	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	4.11e-05	0.00128	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.01e-05	0.00124	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CYP2S1—psoriasis	3.95e-05	0.00123	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CYP2S1—psoriasis	3.94e-05	0.00122	CbGpPWpGaD
Propranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.92e-05	0.00122	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—IFNG—psoriasis	3.92e-05	0.00121	CbGpPWpGaD
Propranolol—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.91e-05	0.00121	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.89e-05	0.00121	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HCAR2—psoriasis	3.83e-05	0.00119	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HCAR2—psoriasis	3.75e-05	0.00116	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—CCL20—psoriasis	3.71e-05	0.00115	CbGpPWpGaD
Propranolol—HTR1B—G alpha (i) signalling events—CXCL8—psoriasis	3.68e-05	0.00114	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HCAR2—psoriasis	3.67e-05	0.00114	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.64e-05	0.00113	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.64e-05	0.00113	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—CCL20—psoriasis	3.63e-05	0.00113	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—JUN—psoriasis	3.61e-05	0.00112	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—CCL20—psoriasis	3.55e-05	0.0011	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.48e-05	0.00108	CbGpPWpGaD
Propranolol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.41e-05	0.00106	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—CCL20—psoriasis	3.37e-05	0.00105	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NDUFA5—psoriasis	3.36e-05	0.00104	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CCL20—psoriasis	3.35e-05	0.00104	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TAGAP—psoriasis	3.32e-05	0.00103	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CCL20—psoriasis	3.3e-05	0.00102	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TAGAP—psoriasis	3.25e-05	0.00101	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CCL20—psoriasis	3.22e-05	0.001	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TAGAP—psoriasis	3.18e-05	0.000986	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NDUFA5—psoriasis	3.17e-05	0.000984	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.16e-05	0.000979	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.12e-05	0.000967	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.12e-05	0.000967	CbGpPWpGaD
Propranolol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	3.09e-05	0.000959	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3e-05	0.00093	CbGpPWpGaD
Propranolol—ADRB3—GPCR ligand binding—CXCL8—psoriasis	2.99e-05	0.000927	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.96e-05	0.000918	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.96e-05	0.000917	CbGpPWpGaD
Propranolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.92e-05	0.000907	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CYP2S1—psoriasis	2.86e-05	0.000886	CbGpPWpGaD
Propranolol—HTR1A—G alpha (i) signalling events—CXCL8—psoriasis	2.8e-05	0.000869	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—TNF—psoriasis	2.71e-05	0.000839	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CYP2S1—psoriasis	2.7e-05	0.000837	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NDUFA5—psoriasis	2.6e-05	0.000805	CbGpPWpGaD
Propranolol—ABCB1—Allograft Rejection—TNF—psoriasis	2.53e-05	0.000786	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NDUFA5—psoriasis	2.53e-05	0.000786	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.52e-05	0.000782	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCL20—psoriasis	2.5e-05	0.000775	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.42e-05	0.000751	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NDUFA5—psoriasis	2.39e-05	0.000741	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.35e-05	0.000731	CbGpPWpGaD
Propranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.33e-05	0.000722	CbGpPWpGaD
Propranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.28e-05	0.000707	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.25e-05	0.000697	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.23e-05	0.000691	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—CXCL8—psoriasis	2.23e-05	0.000691	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CYP2S1—psoriasis	2.21e-05	0.000685	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—IL6—psoriasis	2.18e-05	0.000677	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP2S1—psoriasis	2.15e-05	0.000668	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP2S1—psoriasis	2.03e-05	0.00063	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NDUFA5—psoriasis	2.02e-05	0.000628	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCL20—psoriasis	1.99e-05	0.000617	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCL20—psoriasis	1.95e-05	0.000604	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CARM1—psoriasis	1.93e-05	0.000598	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CARM1—psoriasis	1.93e-05	0.000597	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCL20—psoriasis	1.9e-05	0.000591	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.89e-05	0.000585	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—SOCS1—psoriasis	1.85e-05	0.000573	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—CXCL8—psoriasis	1.77e-05	0.00055	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—TYK2—psoriasis	1.76e-05	0.000546	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—CXCL8—psoriasis	1.73e-05	0.000538	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP2S1—psoriasis	1.72e-05	0.000534	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—CXCL8—psoriasis	1.7e-05	0.000526	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—CXCL8—psoriasis	1.69e-05	0.000524	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.67e-05	0.000518	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.61e-05	0.000499	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NDUFA5—psoriasis	1.56e-05	0.000484	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—CXCL8—psoriasis	1.53e-05	0.000476	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.46e-05	0.000453	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.41e-05	0.000439	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CARM1—psoriasis	1.39e-05	0.000433	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SOCS1—psoriasis	1.38e-05	0.000427	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—LEP—psoriasis	1.36e-05	0.000423	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—APOE—psoriasis	1.36e-05	0.000423	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2S1—psoriasis	1.33e-05	0.000412	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CARM1—psoriasis	1.32e-05	0.000409	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—TYK2—psoriasis	1.31e-05	0.000407	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—NFKBIA—psoriasis	1.27e-05	0.000394	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—CXCL8—psoriasis	1.26e-05	0.00039	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.25e-05	0.000388	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.23e-05	0.000382	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CAT—psoriasis	1.19e-05	0.000368	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CAT—psoriasis	1.18e-05	0.000367	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.16e-05	0.000359	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—CXCL8—psoriasis	1.14e-05	0.000354	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.1e-05	0.000342	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SOCS1—psoriasis	1.1e-05	0.00034	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CARM1—psoriasis	1.08e-05	0.000334	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SOCS1—psoriasis	1.07e-05	0.000333	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CARM1—psoriasis	1.05e-05	0.000326	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SOCS1—psoriasis	1.05e-05	0.000325	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—TYK2—psoriasis	1.04e-05	0.000324	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TYK2—psoriasis	1.04e-05	0.000323	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—TYK2—psoriasis	1.02e-05	0.000317	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—LEP—psoriasis	1.02e-05	0.000315	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—APOE—psoriasis	1.02e-05	0.000315	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.01e-05	0.000313	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	1e-05	0.000311	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—TYK2—psoriasis	1e-05	0.00031	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CARM1—psoriasis	9.91e-06	0.000308	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—CXCL8—psoriasis	9.8e-06	0.000304	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	9.58e-06	0.000297	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NFKBIA—psoriasis	9.46e-06	0.000294	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—APOE—psoriasis	9.22e-06	0.000286	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—APOE—psoriasis	9.2e-06	0.000286	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—CXCL8—psoriasis	9.1e-06	0.000282	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CXCL8—psoriasis	9.06e-06	0.000281	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.01e-06	0.00028	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CXCL8—psoriasis	8.9e-06	0.000276	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CXCL8—psoriasis	8.7e-06	0.00027	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—IL6—psoriasis	8.61e-06	0.000267	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CAT—psoriasis	8.58e-06	0.000266	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—JUN—psoriasis	8.42e-06	0.000261	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CARM1—psoriasis	8.4e-06	0.000261	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—NFKB1—psoriasis	8.1e-06	0.000251	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CAT—psoriasis	8.1e-06	0.000251	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—APOE—psoriasis	8.09e-06	0.000251	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—LEP—psoriasis	8.09e-06	0.000251	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PPARG—psoriasis	8.03e-06	0.000249	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PPARG—psoriasis	8.02e-06	0.000249	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—APOE—psoriasis	7.91e-06	0.000245	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—LEP—psoriasis	7.91e-06	0.000245	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.85e-06	0.000244	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TYK2—psoriasis	7.75e-06	0.00024	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—LEP—psoriasis	7.74e-06	0.00024	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—APOE—psoriasis	7.74e-06	0.00024	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NFKBIA—psoriasis	7.54e-06	0.000234	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NFKBIA—psoriasis	7.37e-06	0.000229	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—VEGFA—psoriasis	7.35e-06	0.000228	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—STAT3—psoriasis	7.28e-06	0.000226	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NFKBIA—psoriasis	7.21e-06	0.000224	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CXCL8—psoriasis	6.75e-06	0.000209	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—APOE—psoriasis	6.66e-06	0.000207	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAT—psoriasis	6.63e-06	0.000206	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CARM1—psoriasis	6.48e-06	0.000201	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAT—psoriasis	6.47e-06	0.000201	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL6—psoriasis	6.42e-06	0.000199	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—APOE—psoriasis	6.3e-06	0.000195	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—JUN—psoriasis	6.27e-06	0.000195	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TYK2—psoriasis	6.17e-06	0.000192	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAT—psoriasis	6.1e-06	0.000189	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NFKB1—psoriasis	6.04e-06	0.000187	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TYK2—psoriasis	6.04e-06	0.000187	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TYK2—psoriasis	5.9e-06	0.000183	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PPARG—psoriasis	5.8e-06	0.00018	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—psoriasis	5.56e-06	0.000172	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PPARG—psoriasis	5.48e-06	0.00017	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—psoriasis	5.48e-06	0.00017	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—psoriasis	5.43e-06	0.000168	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL8—psoriasis	5.37e-06	0.000167	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL8—psoriasis	5.26e-06	0.000163	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAT—psoriasis	5.17e-06	0.00016	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOE—psoriasis	5.15e-06	0.00016	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL8—psoriasis	5.14e-06	0.000159	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—psoriasis	5.11e-06	0.000159	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—psoriasis	5.09e-06	0.000158	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOE—psoriasis	5.03e-06	0.000156	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—psoriasis	5e-06	0.000155	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—JUN—psoriasis	5e-06	0.000155	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—psoriasis	4.89e-06	0.000152	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—JUN—psoriasis	4.89e-06	0.000152	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NFKB1—psoriasis	4.81e-06	0.000149	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—JUN—psoriasis	4.78e-06	0.000148	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOE—psoriasis	4.74e-06	0.000147	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NFKB1—psoriasis	4.7e-06	0.000146	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NFKB1—psoriasis	4.6e-06	0.000143	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARG—psoriasis	4.49e-06	0.000139	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARG—psoriasis	4.38e-06	0.000136	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—psoriasis	4.37e-06	0.000135	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—psoriasis	4.32e-06	0.000134	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—psoriasis	4.27e-06	0.000132	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—psoriasis	4.23e-06	0.000131	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—psoriasis	4.18e-06	0.00013	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—psoriasis	4.14e-06	0.000128	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—psoriasis	4.13e-06	0.000128	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARG—psoriasis	4.13e-06	0.000128	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOE—psoriasis	4.01e-06	0.000125	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAT—psoriasis	3.99e-06	0.000124	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—psoriasis	3.79e-06	0.000118	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARG—psoriasis	3.5e-06	0.000108	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—psoriasis	3.3e-06	0.000102	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—psoriasis	3.23e-06	0.0001	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—psoriasis	3.15e-06	9.79e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOE—psoriasis	3.1e-06	9.61e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—psoriasis	3.02e-06	9.37e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—psoriasis	2.95e-06	9.16e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—psoriasis	2.89e-06	8.96e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARG—psoriasis	2.7e-06	8.37e-05	CbGpPWpGaD
